World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
107
Citations
50173
World Ranking
274
National Ranking
127

Overview

Paul D. Bieniasz is a researcher affiliated with Rockefeller University in the United States. Their academic work primarily focuses on the field of Medicine, with significant contributions to Infectious Diseases, Molecular Biology, Immunology, Animal Science and Zoology, and Radiology, Nuclear Medicine and Imaging.

The scientist's research encompasses several main topics, including SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Animal Virus Infections Studies, SARS-CoV-2 detection and testing, vaccines and immunoinformatics approaches, Monoclonal and Polyclonal Antibodies Research, and Viral Infections and Immunology Research.

Recent notable publications authored or co-authored by Paul D. Bieniasz include:

  • Convergent antibody responses to SARS-CoV-2 in convalescent individuals, 2020, Nature
  • Evolution of antibody immunity to SARS-CoV-2, 2021, Nature
  • mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants, 2021, Nature
  • Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants, 2020, eLife
  • Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies, 2020, Cell

Frequent collaborators of this scientist include:

  • Théodora Hatziioannou
  • Frauke Muecksch
  • Michel C. Nussenzweig
  • Fabian Schmidt
  • Zijun Wang

Paul D. Bieniasz has published extensively in several scientific venues. The most frequent publication venues are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature
  • The Journal of Experimental Medicine
  • PLoS Pathogens
  • Nature Communications

Best Publications

  • A diverse range of gene products are effectors of the type I interferon antiviral response

    John W Schoggins;Sam J. Wilson;Maryline Panis;Mary Y. Murphy

  • Convergent antibody responses to SARS-CoV-2 in convalescent individuals.

    Davide F. Robbiani;Davide F. Robbiani;Christian Gaebler;Frauke Muecksch;Julio C.C. Lorenzi

  • Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

    Stuart J. D. Neil;Trinity Zang;Paul D. Bieniasz

  • Evolution of antibody immunity to SARS-CoV-2.

    Christian Gaebler;Zijun Wang;Julio C. C. Lorenzi;Frauke Muecksch

  • Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.

    Matthew J. Evans;Thomas von Hahn;Donna M. Tscherne;Andrew J. Syder

  • Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.

    Yiska Weisblum;Fabian Schmidt;Fengwen Zhang;Justin DaSilva

  • mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.

    Zijun Wang;Fabian Schmidt;Yiska Weisblum;Frauke Muecksch

  • HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress

    Juan Martin-Serrano;Trinity Zang;Paul D. Bieniasz

  • Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.

    Christopher O. Barnes;Anthony P. West;Kathryn E. Huey-Tubman;Magnus A.G. Hoffmann

  • Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to Cells

    David Perez-Caballero;Trinity Zang;Trinity Zang;Alaleh Ebrahimi;Alaleh Ebrahimi;Matthew W. McNatt;Matthew W. McNatt

  • Vaccine Breakthrough Infections with SARS-CoV-2 Variants.

    Ezgi Hacisuleyman;Caryn Hale;Yuhki Saito;Nathalie E. Blachere

  • Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.

    Zijun Wang;Frauke Muecksch;Dennis Schaefer-Babajew;Shlomo Finkin

  • Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.

    Fabian Schmidt;Yiska Weisblum;Frauke Muecksch;Hans-Heinrich Hoffmann

  • HIV Restriction Factors and Mechanisms of Evasion

    Michael H. Malim;Paul D. Bieniasz

  • HIV therapy by a combination of broadly neutralizing antibodies in humanized mice

    Florian Klein;Ariel Halper-Stromberg;Joshua A. Horwitz;Henning Gruell;Henning Gruell

  • Intrinsic immunity: a front-line defense against viral attack.

    Paul D Bieniasz

  • MX2 is an interferon-induced inhibitor of HIV-1 infection

    Melissa Kane;Melissa Kane;Shalini S. Yadav;Julia Bitzegeio;Julia Bitzegeio;Sebla B. Kutluay;Sebla B. Kutluay

  • Tetherin-Driven Adaptation of Vpu and Nef Function and the Evolution of Pandemic and Nonpandemic HIV-1 Strains

    Daniel Sauter;Michael Schindler;Anke Specht;Wilmina N. Landford

  • Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors.

    Greg J Towers;Theodora Hatziioannou;Simone Cowan;Stephen P Goff

  • Enhanced SARS-CoV-2 neutralization by dimeric IgA.

    Zijun Wang;Julio C. C. Lorenzi;Frauke Muecksch;Shlomo Finkin

  • Evolution of Antibody Immunity to SARS-CoV-2

    Christian Gaebler;Zijun Wang;Julio C C Lorenzi;Frauke Muecksch

  • Corrigendum: A diverse range of gene products are effectors of the type I interferon antiviral response.

    John W. Schoggins;Sam J. Wilson;Maryline Panis;Mary Y. Murphy

Frequent Co-Authors

Theodora Hatziioannou
Theodora Hatziioannou Rockefeller University
Michel C. Nussenzweig
Michel C. Nussenzweig Rockefeller University
Charles M. Rice
Charles M. Rice Rockefeller University
Davide F. Robbiani
Davide F. Robbiani Universita della Svizzera Italiana
Bryan R. Cullen
Bryan R. Cullen Duke University
Stuart J. D. Neil
Stuart J. D. Neil King's College London
John W. Schoggins
John W. Schoggins The University of Texas Southwestern Medical Center
Hal P. Bogerd
Hal P. Bogerd Duke University
Greg J. Towers
Greg J. Towers University College London
Vineet N. KewalRamani
Vineet N. KewalRamani National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology opens doors to diverse career paths, many of which are supported by online education options. For those interested in the intersection of healthcare and technology, pursuing an health information management salary entry-level role is an attractive option. Entry-level positions offer competitive pay and opportunities to grow in the health information sector.

Students seeking quality programs can explore online health information management degree programs cahiim accredited, which ensure that the curriculum meets industry standards and enhances employability.

If you want to jumpstart your career quickly, accelerated pathways such as the medical billing and coding certificate online accelerated programs provide focused training in a short time frame, equipping graduates with essential skills for immediate workforce entry.

More broadly, those interested in healthcare can discover a variety of online medical degrees that complement a background in Microbiology, offering flexible learning options to advance your career in medical and research fields.

Best Scientists Citing Paul D. Bieniasz

Trending Scientists